alanylglutamine has been researched along with Disease Models, Animal in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 15 (65.22) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bartosova, M; Bestvater, F; González Mateo, GT; Hackert, T; Hausmann, M; Herzog, R; Jenei, H; Kratochwill, K; Levai, E; López Cabrera, M; Marinovic, I; Ridinger, D; Schmitt, CP; Zarogiannis, SG; Zhang, C | 1 |
| Hou, YC; Liu, JJ; Pai, MH; Yeh, SL | 1 |
| Chen, HL; Li, JG; Li, Y; Lin, YJ; Liu, ZH; Peng, JS; Song, H; Wu, XB | 1 |
| Bertolo, RF; Brunton, JA; Dodge, ME; Nosworthy, MG | 1 |
| Beelen, RH; Ferrantelli, E; Foster, TL; Keuning, ED; Liappas, G; Lopéz-Cabrera, M; Vervloet, MG; Vila Cuenca, M | 1 |
| Blanc, MC; Bonnefont-Rousselot, D; Cynober, L; De Bandt, JP; Fürst, P; Le Tourneau, A; Nakib, S; Schuster, H | 1 |
| Blázovics, A; Gero, D; Harsányi, L; Hegedus, V; Kiss, A; Kupcsulik, P; Lotz, G; Módis, K; Ónody, P; Stangl, R; Szabó, C; Szijártó, A; Tamás, J; Tátrai, M | 1 |
| Guimarães, SB; Sena, JI; Vasconcelos, PR | 1 |
| Déchelotte, P; Haas, V; Marion-Letellier, R; Mbodji, K; Torre, S | 1 |
| Araújo Júnior, RJ; Garcia, JH; Guimarães, SB; Silva Júnior, RG; Vasconcelos, MP; Vasconcelos, PR | 1 |
| Garcia, JH; Guimarães, SB; Leitão, JP; Santos, JM; Vasconcelos, PR; Vasconcelos, RC | 1 |
| Garcia, JH; Guimarães, SB; Pires, VL; Silva Filho, AR; Souza, JR; Vasconcelos, PR | 1 |
| Costa Neto, CD; Guimarães, SB; Souza, PP; Vasconcelos, PR; Vasconcelos, RC | 1 |
| Chao, CJ; Chu, CC; Hou, YC; Pai, MH; Yeh, SL | 1 |
| Calabrese, GM; Ernst, PB; Figler, RA; Guerrant, RL; Li, Y; Linden, J; Pawlowski, SW; Rieger, J; Warren, CA | 1 |
| Chu, CC; Hou, YC; Ko, TL; Yeh, CL; Yeh, SL | 1 |
| Braga Neto, MB; Costa, LB; Guerrant, RL; Kolling, GL; Li, Y; Lima, AA; Oliveira, RA; Rodrigues, RS; Warren, CA; Zaja-Milatovic, S | 1 |
| Bamba, T; Fujiyama, Y; Satoh, J; Tsujikawa, T | 1 |
| Batmunkh, E; Blázovics, A; Gero, D; Hahn, O; Harsányi, L; Kiss, A; Kupcsulik, P; Lotz, G; Schaff, Z; Stangl, R; Szabó, C; Szijártó, A; Váli, L | 1 |
| Fukushima, R; Furukawa, S; Hashiguchi, Y; Inaba, T; Lin, MT; Muto, T; Naka, S; Saito, H; Wada, N | 1 |
| Argenzio, R; Blikslager, A; Guerrant, R; Hunt, E; Rhoads, M | 1 |
| Carvalho, GH; Figueiredo, AA; Gifoni, AR; Guerrant, RL; Lima, AA; Silva, EA; Soares, AM | 1 |
| Fritsch, A; Funovics, J; Fürst, P; Karner, J; Karner-Hanusch, J; Kovats, E; Roth, E | 1 |
23 other study(ies) available for alanylglutamine and Disease Models, Animal
| Article | Year |
|---|---|
Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid.
Topics: Animals; Biological Transport; Claudin-5; Dialysis Solutions; Dipeptides; Disease Models, Animal; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Peritoneal Dialysis; Single Molecule Imaging; Tight Junctions; Zonula Occludens-1 Protein | 2020 |
Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Dipeptides; Disease Models, Animal; Inflammation; Interleukin-2; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Th17 Cells | 2013 |
Enteral supplementation of alanyl-glutamine attenuates the up-regulation of beta-defensin-2 protein in lung injury induced by intestinal ischemia reperfusion in rats.
Topics: Acute Lung Injury; Animals; beta-Defensins; Dipeptides; Disease Models, Animal; Enteral Nutrition; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha; Up-Regulation | 2014 |
Enterally delivered dipeptides improve small intestinal inflammatory status in a piglet model of intestinal resection.
Topics: Animals; Dipeptides; Disease Models, Animal; Enteral Nutrition; Glutathione; Inflammation; Interferon-gamma; Intestine, Small; Organ Size; Swine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
Topics: Animals; Biomarkers; Cytoprotection; Dipeptides; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Inflammation Mediators; Interleukin-17; Male; Mice, Inbred C57BL; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Protective Agents; Rats, Wistar; Signal Transduction | 2016 |
Protective effects of glutamine dipeptide and alpha-tocopherol against ischemia-reperfusion injury in the isolated rat liver.
Topics: alpha-Tocopherol; Animals; Dipeptides; Disease Models, Animal; Drug Combinations; Glutamine; Glutathione; Liver; Male; Nitric Oxide; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2009 |
Reduction of liver ischemia-reperfusion injury via glutamine pretreatment.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Dipeptides; Disease Models, Animal; Glutamine; In Situ Nick-End Labeling; Ischemic Preconditioning; Laser-Doppler Flowmetry; Liver Circulation; Liver Diseases; Male; Microcirculation; Oxidation-Reduction; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2011 |
Metabolic changes induced by pre-administration of L-alanyl-glutamine and omega-3 in Wistar rats subjected to sepsis.
Topics: Animals; Anti-Inflammatory Agents; Dipeptides; Disease Models, Animal; Fatty Acids, Omega-3; Gluconeogenesis; Glycolysis; Immunologic Factors; Liver; Male; Muscle, Striated; Random Allocation; Rats; Rats, Wistar; Sepsis | 2010 |
Alanyl-glutamine restores maternal deprivation-induced TLR4 levels in a rat neonatal model.
Topics: Animals; Animals, Newborn; Colon; Cyclooxygenase 2; Cytokines; Dietary Supplements; Dipeptides; Disease Models, Animal; Down-Regulation; Female; Irritable Bowel Syndrome; Maternal Deprivation; Membrane Proteins; Occludin; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Toll-Like Receptor 4; Up-Regulation | 2011 |
Preconditioning with L-alanyl-glutamine reduces hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Animals; Dipeptides; Disease Models, Animal; Immunohistochemistry; Ischemia; Ischemic Preconditioning; L-Lactate Dehydrogenase; Liver; Male; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Treatment Outcome | 2011 |
L-alanyl-glutamine dipeptide pretreatment attenuates ischemia-reperfusion injury in rat testis.
Topics: Animals; Dipeptides; Disease Models, Animal; Glutathione; Ischemia; Ischemic Preconditioning; Male; Malondialdehyde; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Spermatic Cord Torsion; Testis; Time Factors; Treatment Outcome | 2011 |
Preconditioning with L-alanyl-L-glutamine in a Mongolian gerbil model of acute cerebral ischemia/reperfusion injury.
Topics: Animals; Blood Glucose; Brain Ischemia; Dipeptides; Disease Models, Animal; Gerbillinae; Ischemic Preconditioning; Lactic Acid; Oxidative Stress; Random Allocation; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome | 2011 |
Effect of glutamine on the mRNA level of key enzymes of malate-aspartate shuttle in the rat intestine subjected to ischemia reperfusion.
Topics: Animals; Aspartate Aminotransferases; Aspartic Acid; Dipeptides; Disease Models, Animal; Glutamine; Intestine, Small; Malate Dehydrogenase; Malates; Random Allocation; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; RNA, Messenger; Time Factors | 2011 |
Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Dipeptides; Disease Models, Animal; Down-Regulation; Haptoglobins; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Peroxidase; Severity of Illness Index; T-Lymphocytes, Helper-Inducer | 2012 |
Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice.
Topics: Adenosine A2 Receptor Antagonists; Animals; Apoptosis; Bacterial Toxins; Clostridioides difficile; Dipeptides; Disease Models, Animal; Enterotoxins; Histocytochemistry; Ileitis; Male; Mice; Mice, Inbred C57BL; Rabbits; Treatment Outcome; Typhlitis | 2012 |
Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Dipeptides; Disease Models, Animal; Down-Regulation; Gastrointestinal Agents; Haptoglobins; Inflammation Mediators; Injections, Intraperitoneal; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Random Allocation; Toll-Like Receptor 4 | 2013 |
Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
Topics: Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Cell Proliferation; Clostridioides difficile; Clostridium Infections; Dipeptides; Disease Models, Animal; Enterocytes; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Necrosis; Rats; Vancomycin | 2013 |
Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide.
Topics: Alanine; Amino Acid Transport Systems; Animals; Antineoplastic Agents, Alkylating; Biomarkers; Body Weight; Cadherins; Carrier Proteins; Cyclophosphamide; Dietary Supplements; Dipeptides; Disease Models, Animal; Enteral Nutrition; Glutamine; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2003 |
Short-term alanyl-glutamine dipeptide pretreatment in liver ischemia-reperfusion model: effects on microcirculation and antioxidant status in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Caspase 3; Dipeptides; Disease Models, Animal; Immunohistochemistry; In Situ Nick-End Labeling; Liver; Male; Microcirculation; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha; Ultrasonography | 2007 |
Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis.
Topics: Amino Acids; Amino Acids, Branched-Chain; Animals; Dipeptides; Disease Models, Animal; Male; Parenteral Nutrition, Total; Peritonitis; Proteins; Rats; Rats, Wistar | 1997 |
Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis.
Topics: Amino Acid Transport Systems; Amino Acid Transport Systems, Basic; Animals; Blotting, Western; Carrier Proteins; Cattle; Chlorides; Cryptosporidiosis; Cyclooxygenase Inhibitors; Dinoprostone; Dipeptides; Disease Models, Animal; Drug Synergism; Glutamine; Ileum; Immunohistochemistry; In Vitro Techniques; Indomethacin; Intestinal Absorption; Ion Transport; Sodium | 2001 |
Effects of an alanyl-glutamine-based oral rehydration and nutrition therapy solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin.
Topics: Animals; Cholera Toxin; Diarrhea; Dipeptides; Disease Models, Animal; Electrolytes; Female; Fluid Therapy; Glutamine; Intestinal Absorption; Kinetics; Male; Potassium; Rats; Rats, Wistar; Rehydration Solutions; Sodium; Water | 2002 |
[Organ-specific in vivo dipeptide (alanylglutamine, glycylglutamine) values in catabolic dogs].
Topics: Animals; Dipeptides; Disease Models, Animal; Dogs; Injections, Intravenous; Kinetics; Tissue Distribution; Wounds and Injuries | 1987 |